Thema: US5288723027
LXRX, US5288723027
stock-4435281_1920.jpg - Foto: THN
Lexicon Pharmaceuticals stock: Q3 results set for November 5
Lexicon Pharmaceuticals stock faces a scheduled financial update as the company prepares its third-quarter release. Management will add a business update.
ad-hoc-news.de, heute 01:29 Uhr
LXRX, US5288723027
Lexicon Pharmaceuticals stock: Cantor keeps USD 8.00 target ...
Cantor Fitzgerald kept USD 8.00 target on October 18, 2026. Lexicon Pharmaceuticals stock posted USD 0.7 million revenue in the second quarter of 2026.
ad-hoc-news.de, 23.10.26 04:53 Uhr
LXRX, US5288723027
Consensus target rises to USD 4.64 for Lexicon Pharmaceuticals ...
Cantor set an Overweight rating and USD 8.00 target on September 28, 2026. SONATA-HCM data are due in Q1 2027 for Lexicon Pharmaceuticals stock.
ad-hoc-news.de, 16.10.26 04:55 Uhr
LXRX, US5288723027
Cantor sets USD 8.00 target for Lexicon Pharmaceuticals ...
Average target rose to USD 4.64 from USD 3.93 on October 2, 2026. For Lexicon Pharmaceuticals stock, first-quarter 2027 data is next.
ad-hoc-news.de, 14.10.26 05:37 Uhr
LXRX, US5288723027
Lexicon Pharmaceuticals stock faces a Q2 loss as trials ...
Lexicon Pharmaceuticals stock posted a USD 31.8 million net loss in Q2 2026, versus USD 3.3 million profit a year earlier. Revenue fell to USD 0.7 million.
ad-hoc-news.de, 07.10.26 05:30 Uhr
LXRX, US5288723027
Fair value rises to USD 4.55 for Lexicon Pharmaceuticals ...
Cantor set a USD 8.00 target for Lexicon Pharmaceuticals stock. Second-quarter revenue was USD 692,000 versus USD 3.99 million consensus.
ad-hoc-news.de, 05.10.26 01:53 Uhr
LXRX, US5288723027
Cantor Fitzgerald targets Lexicon Pharmaceuticals stock ...
Cantor Fitzgerald set USD 8.00 target on September 28, 2026. Lexicon Pharmaceuticals stock was EUR 1.66 on September 29, 2026 versus EUR 1.67.
ad-hoc-news.de, 02.10.26 01:09 Uhr
Lexicon, Pharmaceuticals
Lexicon Pharmaceuticals Approaches Critical Development ...
